Updating results

19 results for Depression in Children and Adolescents

Sort: Relevance | Date

Depression in children and young people

Everything NICE has said on identifying, treating and managing depression in children and young people in an interactive flowchart

NICE Pathway Published May 2011 Last updated June 2019

Bipolar disorder

Everything NICE has said on recognising, assessing and managing bipolar disorder in children, young people and adults in an interactive flowchart

NICE Pathway Published September 2014 Last updated May 2018

Antisocial behaviour and conduct disorders in children and young people

Everything NICE has said on antisocial behaviour and conduct disorders in children and young people in an interactive flowchart

NICE Pathway Published March 2013 Last updated June 2019

Social and emotional wellbeing for children and young people

Everything NICE has said on supporting the social and emotional wellbeing of children and young people in an interactive flowchart

NICE Pathway Published December 2011 Last updated May 2019

Psychosis and schizophrenia

Everything NICE has said on recognising and managing psychosis and schizophrenia in children, young people and adults in an interactive flowchart

NICE Pathway Published February 2014 Last updated August 2019

Attachment difficulties in children and young people

Everything NICE has said on identifying, assessing and treating attachment disorders in under 18s in an interactive flowchart

NICE Pathway Published November 2015 Last updated June 2019

Domestic violence and abuse

Everything NICE has said on identifying, preventing and reducing domestic violence and abuse in an interactive flowchart

NICE Pathway Published February 2014 Last updated August 2017

Autism spectrum disorder

Everything NICE has said on recognition, referral, diagnosis and management of autism in an interactive flowchart

NICE Pathway Published June 2012 Last updated June 2019

Attention deficit hyperactivity disorder in children and young people: lisdexamfetamine dimesylate (ESNM19)

Summary of the evidence on lisdexamfetamine dimesylate for attention defecit hyperactivity disorder (ADHD) in children and young people..

Evidence summary Published May 2013

Attention deficit hyperactivity disorder in children and young people: guanfacine prolonged-release (ESNM70)

Summary of the evidence on guanfacine prolonged-release for attention deficit hyperactivity disorder (ADHD) to inform local NHS planning and decision-making

Evidence summary Published March 2016

Self-harm

Everything NICE has said on assessing and managing self-harm in an interactive flowchart

NICE Pathway Published November 2011 Last updated September 2019

Suicide prevention: optimising medicines and reducing access to medicines as a means of suicide (KTT24)

If a person with a common mental health disorder, in particular depression, is assessed to be at risk of suicide, take into account...

Key therapeutic topic Published March 2019 Last updated September 2019

Alcohol-use disorders

Everything NICE has said on preventing, diagnosing and managing alcohol-related disorders in an interactive flowchart

NICE Pathway Published May 2011 Last updated August 2019

Epilepsy

Everything NICE has said on diagnosing and managing the epilepsies in adults and children in primary and secondary care in an interactive flowchart

NICE Pathway Published January 2012 Last updated October 2019

Management of vomiting in children and young people with gastroenteritis: ondansetron (ESUOM34)

Summary of the evidence on ondansetron for the management of vomiting in children and young people with acute gastroenteritis...

Evidence summary Published October 2014

Learning disabilities and behaviour that challenges

Everything NICE has said on services, prevention and interventions for people with learning disabilities whose behaviour challenges in an interactive flowchart

NICE Pathway Published May 2015 Last updated August 2019

Scleroderma: oral mycophenolate (ESUOM32)

Summary of the evidence on oral mycophenolate for systemic sclerosis (scleroderma) to inform local NHS planning and decision-making

Evidence summary Published July 2014

Generalised anxiety disorder: quetiapine (ESUOM12)

Summary of the evidence on quetiapine monotherapy for treating generalised anxiety disorder (GAD) to inform local NHS planning and decision-making

Evidence summary Published May 2013

Systemic lupus erythematosus: oral mycophenolate (ESUOM36)

Summary of the evidence on oral mycophenolate for systemic lupus erythematosus (SLE) to inform local NHS planning and decision-making

Evidence summary Published November 2014